Register Now for The Outlook on Active Nutrition
Feature|Videos|December 1, 2025

The Benefits of Nattokinase with NSK-SD®

Key Takeaways

  • Understand the research and rigorous testing that support the quality and identity of NSK-SD®.
  • Learn how NSK-SD® may play a role in supporting women’s cardiovascular health.
SHOW MORE

Vincent Hackel, President & CEO of JBSL-USA, shares how NSK-SD® sets the standard in nattokinase science—from research and manufacturing to global opportunities in women’s heart-health innovation.

Sponsored by JBSL-USA

In this interview, Vincent Hackel, President and CEO of JBSL-USA, explores the science and innovation behind NSK-SD®, a nattokinase enzyme derived from non-GMO soybeans and backed by a growing body of clinical research. He explains how JBSL’s proprietary manufacturing process and decades of study distinguish NSK-SD® from other nattokinase ingredients. Hackel also touches on the enzyme’s potential relevance to cardiovascular wellness—including women’s heart health—along with opportunities for product developers to incorporate NSK-SD® into retail formulations. He concludes with a look at the global regulatory landscape and the expanding international demand for clinically supported cardiovascular ingredients.